UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in ROIV — Roivant Sciences Ltd.
CIK 861177
NEW YORK, NY
Position in ROIV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$588,429
-$47,650,565 QoQ
Shares Held
16,627
-99.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#266
of 494 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. ROIV ranks #132 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in ROIV
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $588,429 | 16,627 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $48,238,994 | 1,741,480 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $45,236,011 | 2,084,609 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $32,130,320 | 2,123,617 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $31,278,178 | 2,775,349 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $24,678,190 | 2,445,807 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $28,527,639 | 2,411,466 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $26,624,831 | 2,307,178 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $16,322,456 | 1,544,225 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $12,062,268 | 1,144,428 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $12,876,675 | 1,146,632 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $12,254,654 | 1,049,200 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,024,089 | 300,009 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,214,065 | 300,009 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,605,074 | 326,042 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $877,607 | 272,549 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $963,636 | 236,766 | Shares | Defined | 2022-08-12 | |
| No filing history on record for this holder in this stock. | ||||||